{
  "id": 12654853,
  "title": "Nuvig drops a Phase 2 trial; Cerevance reports Parkinson's progress",
  "url": "https://urgent.news/2026/10/07/nuvig-drops-a-phase-2-trial-cerevance-reports-parkinsons-progress",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T15:20:53.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/nuvig-drops-a-phase-2-trial-cerevance-reports-parkinsons-progress/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about RevMed, Tang Capital, GSK and AmyriAD Therapeutics. Nuvig Therapeutics ends one of two trials: The biotech axed a Phase 2 study of its candidate NVG-2089 in patients with chronic inflammatory demyelinating polyneuropathy ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}